Mutations in the TP53 gene, which occurs in almost 50% of human tumors, are associated with the accumulation of the mutant protein in the nucleus of tumor cells, resulting in increased concentrations in extracellular fluids, such as blood, urine and saliva [74]. This evidence concerns the gene TP53 and neoplasm.